High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 6, 2012, Pages 655-660

  Li, Peng Zhou ^a   Zhu, Shai Hong ^a   He, Wei ^a   Zhu, Li Yong ^a   Liu, Sheng Ping ^a   Liu, Yan ^a   Wang, Guo Hui ^a   Ye, Fei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

High intensity focused ultrasound; Pancreatic cancer; Therapy

Indexed keywords

CA 19-9 ANTIGEN;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ARTICLE; B SCAN; BACKACHE; BURN; CANCER PAIN; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INOPERABLE CANCER; KARNOFSKY PERFORMANCE STATUS; MALE; OVERALL SURVIVAL; PANCREAS CANCER; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 84872141170     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(12)60241-0     Document Type: Article

References (21)

1. Vulfovich M, Rocha-Lima C. Novel advances in pancreatic cancer treatment. Expert Rev Anticancer Ther 2008;8:993-1002.
2. Michl P, Pauls S, Gress TM. Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:227-251.
3. Calle EE, Rodriguez C, Walker K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
4. Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol 2008;190:191-199.
5. Vykhodtseva N, McDannold N, Martin H, Bronson RT, Hynynen K. Apoptosis in ultrasound-produced threshold lesions in the rabbit brain. Ultrasound Med Biol 2001;27:111-117.
6. Jang HJ, Lee JY, Lee DH, Kim WH, Hwang JH. Current and Future Clinical Applications of High-Intensity Focused Ultrasound (HIFU) for Pancreatic Cancer. Gut Liver 2010;4:S57-61.
7. Hwang JH, Wang YN, Warren C, Upton MP, Starr F, Zhou Y, et al. Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol 2009;35:967-975.
8. Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol 2002;28:535-542.
9. N'Djin WA, Melodelima D, Schenone F, Rivoire M, Chapelon JY. Assisted hepatic resection using a toroidal HIFU device: an in vivo comparative study in pig. Med Phys 2011;38:1769-1778.
10. Jiang Z, Holyoak GR, Bartels KE, Ritchey JW, Xu G, Bunting CF, et al. In vivo trans-rectal ultrasound-coupled optical tomography of a transmissible venereal tumor model in the canine pelvic canal. J Biomed Opt 2009;14:030506.
11. Sung HY, Jung SE, Cho SH, Zhou K, Han JY, Han ST, et al. Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas 2011;40:1080-1086.
12. Brescia FJ, Portenoy RK, Ryan M, Krasnoff L, Gray G. Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol 1992;10:149-155.
13. Rosenschein U, Furman V, Kerner E, Fabian I, Bernheim J, Eshel Y. Ultrasound imaging-guided noninvasive ultrasound thrombolysis: preclinical results. Circulation 2000;102:238-245.
14. Sofuni A, Moriyasu F, Sano T, Yamada K, Itokawa F, Tsuchiya T, et al. The current potential of high-intensity focused ultrasound for pancreatic carcinoma. J Hepatobiliary Pancreat Sci 2011;18:295-303.
15. Wu F, Wang ZB, Cao YD, Xu ZL, Zhou Q, Zhu H, et al. Heat fixation of cancer cells ablated with high-intensity-focused ultrasound in patients with breast cancer. Am J Surg 2006; 192:179-184.
16. Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology 2005;236:1034-1040.
17. Li CX, Xu GL, Jiang ZY, Li JJ, Luo GY, Shan HB, et al. Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J Gastroenterol 2004;10:2201-2204.
18. Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP 2009;10:123-129.
19. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-2413.
20. Wang K, Chen Z, Meng Z, Lin J, Zhou Z, Wang P, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia 2011; 27:101-107.
21. Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, et al. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol 2007;25:2212-2217.